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1. Introduction 
Patients in cardiogenic shock, with severely impaired left ventricular function, or 
intervention on the last open supplying coronary artery are summarized as so called “high 
risk coronary interventions” with significant risk of hemodynamic collapse and increased 
periprocedural mortality rate [1]. Thus, high risk percutaneous coronary interventions (PCI) 
may require prophylactic or standby hemodynamic mechanical circulatory support. While 
infusion of inotropic substances further increases myocardial oxygen consumption, other 
measures of support may be favourable especially in infarct related acute pump failure.  
However, in acute cardiogenic shock, mechanical circulatory support may depict the only 
option to stabilise the patient for intra- or inter-hospital transfer and further diagnostic 
and therapeutic measures. This chapter summarises different therapeutic options of 
mechanical circulatory support in high risk PCI patients. Ongoing technical development 
as well as clinical studies may further elucidate this field of interventional cardiology in 
the future. 
2. Identification of high risk PCI patients and indication for mechanical 
circulatory support 
Cardiogenic shock is defined as reduction of cardiac index to less than 2.2 l/min/m² and 
increase in pulmonary capillary wedge pressure above 18 mmHg. Patients present with 
systolic blood pressure below 100 mmHg, tachycardia of more than 100 bpm, oliguria or 
anuria, cold and pale extremities, and impairment of cognitive function. The infusion of 
volume does not result in termination of shock. One-month-mortality rates of cardiogenic 
shock range between 40% and 80%. Cardiogenic shock can be caused by multiple reasons 
(table 1). However, acute myocardial infarction (AMI) accounts for more than 80% of cases. 
Fastest possible coronary revascularisation is recommended in patients suffering from AMI 
related cardiogenic shock [2]. 
Some cardiogenic shock patients with ongoing CPR require mechanical circulatory support 
upfront to make coronary angiography and/or PCI feasible. Besides catecholamine infusion, 
mechanical circulatory support provides an increase in arterial blood pressure and therefore 
in organ perfusion resulting in an improvement of organ function. The prognosis of shock 
patients is determined by the occurrence of a multi organ dysfunction syndrome (MODS) 
associated with an extremely high mortality. Hemodynamic support should increase arterial 
blood pressure to values above 70 mmHg for prevention or reversal of beginning MODS. 
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- Myocardial ischemia, myocardial infarction  
- Myocarditis 
- Dilatated cardiomyopathy 
- Hypertrophic or restrictive cardiomyopathy 
- Takotsubo-Syndrome 
- Cardiotoxic substances (intoxication, cytostatics, drugs) 
- Cardiodepressive substances (ß-blockers, Ca-antagonists, drugs, 
antiarrhythmic-, or antidepressive medication) 
Rhythm related 
pump failure 
- Supra-ventricular tachycardia or bradycardia 
- Conductance disorders (AV-block, pre-excitation) 
- Ventricular tachycardia or bradycardia 
- Asystoly, electro-mechanical discordance 
Mechanical 
problems 
- Valvular heart disease (stenosis, insufficiency) 
- Mechanical complications of infarction (rupture of papillary 
muscle, ventricular septum or wall) 
- Cardiac tamponade 
- Pericarditis constrictiva 
- Intra-cavity thrombus 
- Hypertrophic obstructive cardiomyopathy 
- Aortic dissection 
Table 1. Reasons of acute cardiogenic shock 
Three groups of patients requiring mechanical circulatory support in the catheter laboratory 
can be identified: 
1. Acute pump failure or circulatory arrest with cardiogenic shock. 
2. Elective high risk PCI patients requiring prophylactic or standby support if the risk for 
hemodynamic collapse is relatively high. 
3. Effective hemodynamic stabilisation for transfer of shock patients to other departments 
or other heart centres (e.g. cardiac surgery). 
While patients in group 1 and 3 can be easily identified by clinical judgement and 
hemodynamic evaluation, the indication for mechanical support in high risk elective PCI is 
still based on individual judgement, although scoring systems like Jeopardy Score or 
Bergelson’s Score may help in the clinical process of decision making [3]. While elective 
circulatory support can be recommended in patients with severely impaired left ventricular 
ejection fraction, the standby of assist devices is also an option in hemodynamically stable 
patients. 
High risk PCI is defined as PCI of target vessel supplying more than 50% of vital 
myocardium, or as PCI in unstable patients with an impaired left ventricular ejection 
fraction below 25% [1]. Several scoring systems may help to identify high risk PCI 
candidates based on the coronary anatomy. The Jeopardy Score introduced by Califf et al. in 
1988 divides coronary circulation in six major areas. In case of occlusion or severe stenosis 
each segment accounts one point, in case of akinesia in the area only 0.5 points. If this 
analysis of the coronary tree adds to more than 3 points the patient is endangered for 
hemodynamic collapse during PCI [4]. However, all scoring systems origin from data bases 
of the late 80´s and 90´s when direct stenting and rapid exchange coronary devices were not 
available in the same extend as today. Due to lack of validated scoring systems, the 
application of surgical scoring systems like STS- or revised Euro-Score may support the 
www.intechopen.com
 
Coronary Interventions with Mechanical Circulatory Support 
 
161 
process of clinical decision making for use of circulatory support in high risk PCI. Recent 
studies suggested a benefit of prophylactic circulatory support with the Impella™ in 
comparison to an intra aortic balloon pump (IABP) in elective high risk patients [5]. 
However, this study had relatively high 30-day event rates (Impella 15.3%, IABP 21.3%), 
which requests for further clinical trials. The optimal decision is mostly based on the 
individual situation of the patient and the experience of the operator. 
3. Mechanical circulatory support devices in the catheter laboratory 
3.1 Intra aortic balloon pump (IABP) 
The concept of intra aortic counter pulsation was already introduced in the 50`s by the 
Kantrowitz brothers [6]. They showed an improvement in coronary blood flow when 
offering a delayed blood pressure pulse to the coronary circulation. Further technical 
developments included electrical stimulation of muscles wrapped around the abdominal 
aorta until the final design of an intra aortic balloon with a synchronised counter pulsation 
was introduced in cardiac surgery [7]. In the 70´s, IABP use increased for treatment of acute 
myocardial infarction and cardiogenic shock. In case of thrombolytic therapy, IABP 
significantly improved survival as described in the TIMI-18 study [8]. Today, use of IABP in 
infarct related cardiogenic shock after successful PCI is under controversial discussion [9]. 
However, IABP is recommended in cardiogenic shock before and after cardiac surgery, and 
in acute AMI patients before coronary revascularisation to improve hemodynamic situation. 
An IABP consists of a helium filled balloon in the descending aorta which is inflated and 
deflated in a counter pulsating way to the contractions of the left ventricle. Coronary and 
cerebral diastolic perfusion is increased by abrupt inflation in the early diastolic phase, 
increasing diastolic blood pressure significantly. However, coronary perfusion is only 
improved in the presence of hemodynamically relevant stenosis. An abrupt evacuation 
during systole results in reduction of afterload, therefore increasing left ventricular ejection 
fraction (LVEF) of about 10%. The combination of better diastolic organ perfusion and 
systolic afterload reduction can improve cardiac output by up to 1 l/min in severe 
cardiogenic shock. The 7F IABP catheter can be easily inserted in Seldinger’s technique via 
femoral access. Today, the majority of IABP catheters are inserted in a sheathless way. In 
some cases, subclavian access can also be used for IABP placement. 
4. Axial flow pumps 
The concept of continuous left ventricular unloading with an axial flow pump was 
introduced 25 years ago [10]. The first concept was realized with the Hemopump™ which 
was driven by an external motor sucking blood through a pump cannula from the left 
ventricle into the ascending aorta with a small impeller in the distal part of the cannula. 
Further technical developments included the AMED™-System with the impeller in the 
descending aorta, avoiding any kinking of the drive line [11]. Today, the ImpellaTM-System 
is well established in clinical routine. It consists of a pump cannula containing a micro motor 
and an impeller in its distal end. No external motor is necessary to provide flow rates of 2.5 
and up to 5 l/min according to the pump sizes. The continuous unloading of the left 
ventricle establishes continuous flow into the ascending aorta and rhythm independent 
increase of arterial blood pressure. Especially in acute myocarditis patients, the Impella has 
several beneficial effects on the myocardium and the whole circulation. 
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5. Centrifugal pumps 
Centrifugal pumps allow high flow rates of more than 5 l/min. While the TandemHeart™ 
uses a transseptal venous cannula, placed with its tip in the left atrium, other systems drain 
the blood through a venous cannula from the right atrium. The TandemHeart™ transfers 
the oxygenated blood from the left atrium through the centrifugal pump into the abdominal 
aorta without additional oxygenation. In case of dislocation of the pump cannula the 
patients are endangered of an abrupt deoxygenation. 
Centrifugal pumps with an included membrane oxygenator allow biventricular support 
taking over completely myocardial and pulmonary functions. The blood from right atrium 
and cava vein is delivered by the centrifugal pump through the oxygenator back into the 
abdominal aorta with high flow rates after optimal gas exchange. Thus, these portable 
cardiopulmonary support devices (pCPS) can be also used in complete circulatory arrest. 
Miniaturized pCPS systems like the Lifebridge™ allow intra- or inter-hospital patient 
transfer with optimal oxygenation and organ perfusion. Since emergency pCPS can be 
inserted percutaneously, these devices are also recommended in cardiopulmonary 
resuscitation when other means fail to re-establish circulation. External cardiac compression 
devices like the Lucas™ or Autopulse™-System may be helpful to maintain minimal 
circulation until the cannulas are placed through the femoral vessels by Seldinger’s 
technique. Percutaneous cannulation allows insertion of cannula sizes between 15 and 21 
French without interruption of chest compression. Coronary angiography can be performed 
by contra-lateral approach in Judkin’s technique or brachial approach after transfer of the 
patient to the catheter laboratory. 
 
 
Fig. Options of percutaneous circulatory support in high risk coronary patients (mod. 
according to [12]). 
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6. Duration of support and weaning 
Mechanical circulatory support may be necessary in cardiogenic shock patients for several 
days until hemodynamic recovery. In elective high risk PCI, the device can be removed 
immediately after the intervention. In some cases percutaneous closure devices may be 
helpful. However, removal of cannulas up to diameters of 20 French is also possible under 
local compression and application of a compression bandage for 24 hours. 
7. Limitations and future perspectives 
Mechanical circulatory support in high risk PCI and cardiogenic shock allows hemodynamic 
stabilization in the acute phase especially during the intervention. Continuous sufficient 
organ perfusion reduces the rate of shock related MODS. However, foreign surfaces lead to 
artificial alteration and stimulation of blood cells causing systemic inflammatory response 
syndrome (SIRS). The time of mechanical circulatory support should be therefore as short as 
possible. Additional problems are associated with haemolysis and the need for 
anticoagulation. New coating techniques and optimal design of pump cannulas reduce these 
clinical problems. Future developments include right heart support devices and foldable 
systems which can be inserted through minimal diameter peripheral sheaths. After 
unfolding in the circulation, these devices provide powerful circulatory support [13]. 
Mechanical support devices are useful tools in a catheter laboratory in close cooperation 
with cardiac surgery. Some patients with CPR do not recover despite successful coronary 
revascularisation. Long term circulatory support or heart transplantation may be an option 
in selected cases [14]. If mechanical complications of myocardial infarction are present in the 
state of cardiogenic shock, further surgical therapy is recommended, too. The use of 
circulatory support devices also includes combinations (e.g. CPB and IABP) for a staged 
weaning process. Future devices may allow the combination of techniques by modification 
of the cannulas and pump catheters. Immunologic interventions will focus on prevention of 
SIRS and improved functional recovery of MODS. 
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